Novartis

By Jonah Comstock October 3, 2017
All of the diverse operations of Verily, the life sciences technology company that began its life as Google X Life Sciences, can be summed up with a simple sentence: We should be treating our bodies at least as well as we treat our cars. At the Health 2.0 Fall Conference in Santa Clara this week, Verily Chief Technology Officer Brian Otis spoke with Health 2.0 cofounder and CEO Dr. Indu Subaya on...
By Heather Mack June 8, 2017
Novartis and IBM Watson are working together on a new initiative to improve cancer care. In what the pharmaceutical company called a “first-of-its-kind collaboration, the two will use IBM Watson’s cognitive computing tools to leverage Novartis’s portfolio of breast cancer compounds and real-world patient data. The goal is to use data analytics and machine learning to determine which combinations...
By Heather Mack June 2, 2017
It’s been six years since IBM first alluded to plans to build artificially intelligent physician’s assistant. Even as that mission became more concrete with a formal launch of the health-focused Watson and years of near-constant announcements and partnerships, it still hasn’t been clear just exactly what impact the cognitive computing program will have on healthcare. But newly shared data could...
By Heather Mack March 1, 2017
Digital approaches to healthcare may have the potential to significantly expand coverage and improve the quality and efficiency of patient care, but implementing these new technologies come with challenges of their own, including fragmented data streams, limited resources and ineffective collaboration across multiple sectors. What’s more, access to most basic requirement of digital health...
By Naomi Fried February 10, 2017
About the author: Naomi Fried, PhD (@NaomiFried), is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation infrastructure consulting to healthcare stakeholders including pharma companies and providers. Her previous positions include the first Chief Innovation Officer at Boston Children’s Hospital, Biogen’s VP of Innovation and External Partnerships, and VP...
By Heather Mack February 8, 2017
Digital respiratory health management company Propeller Health is collaborating with Novartis to develop a custom add-on sensor for the Swiss pharmaceutical company’s Breezhaler inhaler, which is used for Novartis’s portfolio of COPD treatments. The partnership will be focused in Europe. The add-on sensor will be developed to work with the capsule-based dry powder inhaler by passively recording...
By Heather Mack November 21, 2016
When will Novartis and Google begin testing the autofocus contact lens they have been developing? Well, there’s still no clear date in sight. The pharmaceutical company announced late last week they had done away with a 2016 goal of testing a smart contact lens for people with nearsightedness, telling Reuters, “It is too early to say when exactly human clinical trials for these lenses will begin...
By Jonah Comstock September 19, 2016
Can the success of digital health coaching apps like Twine Health and WellDoc be ported over to the clinical trial space? According to Joris Van Dam, a strategic projects leader in pharmaceutical development at Novartis, it can and it should. Van Dam spoke at the Mobile in Clinical Trials event today, put on by The Conference Forum.  "The use [of coaching in clinical trials] is a natural fit," he...
By Jonah Comstock June 20, 2016
Exco InTouch has launched a new app that creates a disease-specific social network for people with chronic urticaria, or hives. The app, called Target My Hives, was developed with funding and support from Novartis. The app, available on Android and Apple devices, was just formally announced by the companies, but it currently has 2,000 patients registered from 61 countries. It launched in May....
By Jonah Comstock June 1, 2016
Medella Health, the company whose founding team includes a Thiel Fellow and is racing Google and Novartis to develop a glucose-sensing contact lens, has raised $1.4 million in funding. Backers include 1517 Fund, Fifty Years Fund, Garage Capital, BDC Capital and others.  Not too much is known yet about Medella's lens. The company says it will integrate a small sensor, a chip, and a micro-antenna...